Located on the unceded territory of the Anishinaabe-Algonquin people, in the heart of the nation`s capital and in close proximity to multiple national agencies, the University of Ottawa is one of Canada's top ten research-intensive universities. It is recognised as the first and largest bilingual university in North America and offers strong connections to organisational, government and policy interest holders.
We are interested in attracting an internationally recognized leader in cutting-edge convergence approaches to data analytics and predictive modelling to drive a transformation in brain-heart research and health outcomes. Recognized for building scientific collaborations and knowledge mobilization across disciplines, sectors and countries, the candidate will bring exceptional creativity and demonstrated contributions to the evidence base, matched by a track record of impact on health practices, systems or policy. Their research program may include but is not limited to:
- Multidisciplinary methodologies that integrate large-scale data sources such as population, clinical, ‘omics and administration databases and cohorts; biobanks and research datasets (biological, biomarkers, imaging).
- Integrating novel analytics tools and methods, including artificial intelligence and machine learning.
- Precision risk phenotyping to characterize trajectories and interactions between brain and heart conditions and/ or co-morbidities across the lifespan.
- Developing novel markers and tools for risk detection or early diagnosis of brain-heart risk.
- Developing personalized prognostic models, and prevention, surveillance and treatment strategies.
- Investigating intersectional factors of brain and heart health risk to create models and precision tools that prioritize the most vulnerable populations.
The successful candidate will become an integral part of our dynamic and research-intensive environment with access to state-of-the-art facilities and strong support from the University of Ottawa Heart Institute and University of Ottawa, where brain-heart research has been identified as a strategic priority within our 'Health' research mandate. This environment encompasses the Faculty of Medicine’s clinical departments (e.g., Department of Medicine), as well as departments of Biochemistry, Microbiology and Immunology (BMI), Cellular and Molecular Medicine (CMM), School of Epidemiology and Public Heath (SEPH), and the Department of Innovation in Medical Education (DIME).
The candidate will be a member of the Brain-Heart Interconnectome (BHI). The BHI is a ground-breaking interdisciplinary research program aimed at accelerating prevention, detection, treatment and care of interconnected brain and heart disorders through research co-produced with patients and other knowledge users.
Tier 1 Chairs: Tier 1 Chairs, tenable for seven years and renewable once, are for outstanding researchers, acknowledged by their peers as world leaders in their field. For each Tier 1 Chair, the institution receives $200,000 annually for seven years. Nominees for Tier 1 Chair positions must be full professors or associate professors who are expected to be promoted to the full professor level within one or two years of the nomination. Alternatively, if they come from outside the academic sector, nominees must possess the necessary qualifications to be appointed at these levels. New CRC nominees are also eligible for infrastructure support from the Canada Foundation for Innovation (CFI) to help acquire state-of-the-art equipment essential to their work.